Approximately 6.7 million Americans over the age of 20 have heart failure, according to a new data-driven analysis published by the Heart Failure Society of America (HFSA). That number is expected to rise, the group added, and could hit approximately 11.4 million by 2050.
Those were just some of the eye-opening statistics included in a new HFSA report published in the Journal of Cardiac Failure.[1] In addition, the group wrote, approximately one in four Americans will develop HF in their lifetime. And the odds are even greater for Black individuals than those from other racial and ethnic groups.
An updated perspective from the Heart Failure Society of America
HFSA released its first report dedicated to heart failure trends and outcomes in 2023, planning to release an update every year. This latest update is the third edition of that report. It includes new sections on such topics as hypertrophic cardiomyopathy, cardiovascular-kidney-metabolic health and the cost effectiveness of different therapies.
“Heart failure is a growing epidemic affecting millions of individuals across all demographics,” Gregg C. Fonarow, MD, writing group chair and director of the Ahmanson-UCLA Cardiomyopathy Center, said in a statement. “With a surge in mortality and continued underutilization of evidence-based therapies, it is imperative to prioritize improvements in the prevention, diagnosis, and treatment of heart failure.”
